Risks for Neurologic, Psychiatric Sequelae Persist After COVID-19
FRIDAY, Sept. 2, 2022 (HealthDay News) — Risk for certain neuropsychiatric sequelae remains increased up to two years after COVID-19 infection, according to a study published online Aug. 17 in The Lancet Psychiatry.
Maxime Taquet, Ph.D., from the…
Learn MoreUnos esteroides de uso común podrían alterar al cerebro
MIÉRCOLES, 31 de agosto de 2022 (HealthDay News) — El uso de esteroides a largo plazo puede remodelar a la estructura del cerebro, y hacer que algunas partes se encojan y otras crezcan, informa un nuevo e importante estudio.Las personas que toman est…
Learn MoreUnos esteroides de uso común podrían alterar al cerebro
MIÉRCOLES, 31 de agosto de 2022 (HealthDay News) — El uso de esteroides a largo plazo puede remodelar a la estructura del cerebro, y hacer que algunas partes se encojan y otras crezcan, informa un nuevo e importante estudio.Las personas que toman est…
Learn MoreHow ‘This Is Us’ Put Alzheimer’s Care in the Spotlight
THURSDAY, Sept. 1, 2022 (HealthDay News) — When the wildly popular TV show “This Is Us” wrapped up its final season this year, it did so with a storyline that showed one of the lead characters dealing with Alzheimer’s disease as her adult children di…
Learn MoreWidely Used Steroid Meds Could Alter the Brain
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Long-term steroid use can reshape the structure of the brain, causing some parts to shrink and others to grow, a major new study reports.People taking steroids — even inhaled steroids — appear to have les…
Learn MoreLupus, MS and Other Autoimmune Disorders Raise Heart Risks
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Research has linked heart disease to specific autoimmune diseases such as rheumatoid arthritis and lupus. Now, a huge study shows that autoimmune diseases as a group increase your chances of developing hear…
Learn MoreUblituximab Bests Teriflunomide in Relapsing Multiple Sclerosis
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Patients with relapsing multiple sclerosis receiving ublituximab have lower annualized relapse rates and fewer brain lesions on magnetic resonance imaging than those receiving teriflunomide, according to a …
Learn MoreMultiple Chemical Sensitivity ID’d in Some Migraine Patients
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — One in five migraine patients has multiple chemical sensitivity (MCS), according to a study recently published in the Journal of Occupational Health.
Keisuke Suzuki, M.D., Ph.D., from Dokkyo Medical Uni…
Learn MoreSchool Sports Are Starting Again: Know the Signs of Concussion
SUNDAY, Aug. 28, 2022 (HealthDay News) — As high school sports get underway this fall, sports medicine specialists remind athletes, parents and coaches that concussions can be challenging to diagnose.Dr. Sean Bradley, a primary care sports medicine p…
Learn MoreUn nuevo tratamiento para la EM se muestra promisorio en un ensayo
JUEVES, 25 de agosto de 2022 (HealthDay News) — Una terapia experimental de anticuerpos para la esclerosis múltiple (EM) puede reducir las exacerbaciones de síntomas a la mitad, en comparación con el tratamiento estándar, encontró un nuevo ensayo clí…
Learn More